Skip to main content
. 2019 Jul 9;38:296. doi: 10.1186/s13046-019-1290-0

Fig. 7.

Fig. 7

Illustration of IPO5 involvement in CRC. IPO5 interacts with the NLS sequence of RASAL2 leading to RASAL2 nuclear transposition, This preventing RASAL2 from functioning as a RAS signaling pathway suppressor in the cytoplasm. Thus resulting in RAS signal activation and CRC growth and metastasis